WOOJUNG BIO (Korea) Top Management
215380 Stock | KRW 1,675 23.00 1.35% |
WOOJUNG BIO employs about 10 people. The company is managed by 9 executives with a total tenure of roughly 35 years, averaging almost 3.0 years of service per executive, having 1.11 employees per reported executive. Analysis of WOOJUNG BIO's management performance can provide insight into the company performance.
Byeong Cheon CEO Chief Executive Officer, Director |
WOOJUNG |
WOOJUNG BIO Management Team Effectiveness
The company has return on total asset (ROA) of (0.0566) % which means that it has lost $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (24.1357) %, meaning that it generated substantial loss on money invested by shareholders. WOOJUNG BIO's management efficiency ratios could be used to measure how well WOOJUNG BIO manages its routine affairs as well as how well it operates its assets and liabilities.WOOJUNG BIO Workforce Comparison
WOOJUNG BIO is rated third in number of employees category among its peers. The total workforce of Biotechnology & Medical Research industry is presently estimated at about 188. WOOJUNG BIO holds roughly 10.0 in number of employees claiming about 5% of stocks in Biotechnology & Medical Research industry.
The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.18) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.18. WOOJUNG BIO Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. WOOJUNG BIO Price Series Summation is a cross summation of WOOJUNG BIO price series and its benchmark/peer.
WOOJUNG BIO Notable Stakeholders
A WOOJUNG BIO stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as WOOJUNG BIO often face trade-offs trying to please all of them. WOOJUNG BIO's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting WOOJUNG BIO's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Byeong Cheon | Chief Executive Officer, Director | Profile | |
Tae Uhm | Director | Profile | |
Chan Hong | Director | Profile | |
Ji Lee | Non-Executive Independent Director | Profile | |
Jin Kim | Director | Profile | |
Sang Byun | Non-Executive Independent Director | Profile | |
Jong Ahn | Director | Profile | |
Sang Ahn | Internal Auditor | Profile | |
Geon Oh | Internal Auditor | Profile |
About WOOJUNG BIO Management Performance
The success or failure of an entity such as WOOJUNG BIO often depends on how effective the management is. WOOJUNG BIO management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of WOOJUNG management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the WOOJUNG management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea. WOOJUNG BIO is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of WOOJUNG BIO's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, WOOJUNG BIO's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of WOOJUNG BIO's management manipulating its earnings.
WOOJUNG BIO Workforce Analysis
Traditionally, organizations such as WOOJUNG BIO use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare WOOJUNG BIO within its industry.WOOJUNG BIO Manpower Efficiency
Return on WOOJUNG BIO Manpower
Revenue Per Employee | 3.1B | |
Revenue Per Executive | 3.5B | |
Net Loss Per Employee | 192.6M | |
Net Loss Per Executive | 214M |
Complementary Tools for WOOJUNG Stock analysis
When running WOOJUNG BIO's price analysis, check to measure WOOJUNG BIO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WOOJUNG BIO is operating at the current time. Most of WOOJUNG BIO's value examination focuses on studying past and present price action to predict the probability of WOOJUNG BIO's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WOOJUNG BIO's price. Additionally, you may evaluate how the addition of WOOJUNG BIO to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stocks Directory Find actively traded stocks across global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |